Mary Horowitz, MD, MS

Tacrolimus

2 trials

phase_2phase_3

Mycophenolate Mofetil

2 trials

Cyclosporine A

Single Umbilical Cord Blood Unit Transplant

Total Body Irradiation (TBI)

phase_2

Methotrexate

Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate

A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002)

+10 more interventions

18 unique interventions4 categories

Analytics

Trial Phases

Phase 22

Phase 33

Trial Status

Completed4

Terminated1

Role Distribution

Other Roles5

Activity Timeline

Clinical Trials (5)

NCT04934670Phase 3Terminated

Steroid-Refractory Acute Graft Versus Host Disease

StudydirectorStart date: 2022-06-16

NCT03959241Phase 3Completed

TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

Acute LeukemiaChronic Myelogenous Leukemia (CML)Lymphoma+1 more

StudydirectorStart date: 2019-06-25

NCT02918292Phase 2Completed

Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)

Severe Aplastic Anemia

StudydirectorStart date: 2017-07-03

NCT02806947Phase 2Completed

A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501)

Acute GVHD

StudydirectorStart date: 2016-10-01

NCT00412360Phase 3Completed

Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)

Acute Lymphocytic LeukemiaAcute Myelogenous LeukemiaChronic Myelogenous Leukemia+2 more

Studydirector

Research Network

Collaboration Network

2 collaborators·1 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Leukemia, Myelogenous, Chronic, BCR-ABL Positive2 Acute GVHD1 Acute Leukemia1 Precursor Cell Lymphoblastic Leukemia-Lymphoma1 Leukemia, Myeloid, Acute1 Lymphoma1 Myelodysplasia1 Myelodysplastic Syndromes1

Affiliations

Center for International Blood and Marrow Transplant Research

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

24 trials

Shared therapeutic areas:

LymphomaAcute LeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL Positive+4 more

Worked with same sponsors:

Blood and Marrow Transplant Clinical Trials NetworkMedical College of Wisconsin+3 more

Similarity Score19%

Willem Klaasen

Xenikos, BV

1 trials

Shared therapeutic areas:

Steroid-refractory Acute Graft Versus Host Disease

Worked with same sponsors:

Blood and Marrow Transplant Clinical Trials NetworkNational Cancer Institute (NCI)+3 more

Collaborated on 1 trial

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL Positive+2 more

Beata Holkova, MD

Massey Cancer Center

3 trials

Shared therapeutic areas:

Worked with same sponsors:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic Syndromes+2 more

Jorge Cortes, MD

M.D. Anderson Cancer Center

24 trials

Shared therapeutic areas:

Worked with same sponsors:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesAcute Leukemia+2 more

Qifa Liu

Nanfang Hospital, Southern Medical University

33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic Syndromes+1 more

Arnon Nagler, MD

Chaim Sheba Medical Center

12 trials

Shared therapeutic areas:

Similarity Score11%

Yves Beguin, MD, PhD

CHU-ULg

7 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, Acute+1 more

Similarity Score11%

David Avigan, MD

Beth Israel Deaconess Medical Center

17 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL Positive+1 more

Worked with same sponsors:

National Cancer Institute (NCI)National Heart, Lung, and Blood Institute (NHLBI)

Similarity Score11%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLymphoma

Worked with same sponsors:

Leukemia, Myeloid, AcuteLymphomaMyelodysplastic Syndromes

Similarity Score8%

Areej El-Jawahri, MD

Massachusetts General Hospital

21 trials

Shared therapeutic areas:

Worked with same sponsors: